The Translational Immunology Schools (TIS) up to now were great success stories with participants from both academic research as well as clinical research institutions and industry.

The topics covered include developments in diagnostics, new research technologies, modern immune intervention and new immune therapeutic principles. The registration 2026 is open and attendance is limited to 50 participants.